protein
nanocag
explor
potenti
carrier
biomedicin
form
selfassembl
protein
subunit
cage
structur
three
surfac
engin
interior
exterior
intersubunit
therapeut
diagnost
molecul
load
interior
nanocag
extern
surfac
engin
enhanc
biocompat
target
abil
modif
intersubunit
interact
shown
modul
selfassembl
profil
implic
tune
molecular
releas
review
natur
synthet
protein
nanocag
modifi
use
chemic
genet
engin
techniqu
impart
nonnatur
function
respons
complex
cellular
microenviron
malign
cell
deliv
molecular
cargo
improv
effici
minim
toxic
smart
nanos
materi
high
stabil
suitabl
pharmacokinet
effici
cell
permeabl
deliv
cargo
molecul
target
cell
requir
ideal
drug
deliveri
system
advanc
design
fabric
synthet
carrier
cation
liposom
micel
block
copolym
carbon
nanotub
dendrim
inorgan
nanoparticl
restrict
sever
toxic
low
deliveri
effici
naturederiv
nanocarri
potenti
altern
synthet
one
satisfi
key
featur
biocompat
water
solubl
high
cellular
uptak
effici
minim
toxic
exampl
naturederiv
nanocarri
includ
protein
nanocag
virus
ferritin
mani
other
form
selfassembl
protein
subunit
result
cagelik
structur
monodispers
subunit
modifi
chemic
genet
method
key
biomed
applic
involv
use
protein
nanocag
focu
review
therapeut
diagnost
among
myriad
naturederiv
nanocarri
proteinbas
biolog
system
virus
subject
intens
studi
owe
innat
abil
penetr
cell
membran
structur
virus
best
repres
principl
protein
assembl
natur
structur
analys
virus
show
consist
protein
shell
compris
definit
number
subunit
surround
protect
genom
viral
capsid
natur
program
hostcel
target
cell
entri
evolv
mediat
exchang
nucleic
acid
differ
chemic
environ
virus
stabl
structur
abil
withstand
environment
pressur
sensit
enough
detect
signal
chang
signal
cellular
environ
therebi
releas
nucleic
acid
carri
target
microenviron
virus
thu
inspir
develop
divers
selfassembl
protein
nanocag
natur
sourc
import
aspect
protein
nanocag
biocompat
function
divers
biolog
fabric
flexibl
design
protein
engin
make
power
materi
variou
applic
virus
engin
perform
specif
function
exampl
bacteriophag
use
peptid
display
filament
phage
use
templat
nanofabr
viruslik
particl
vlp
use
immunogen
except
peptidedisplay
filament
phage
commonli
use
nucleic
acid
conjug
drug
deliveri
vitro
vivo
nanoparticl
hardli
suitabl
celltarget
drug
deliveri
specif
function
polypeptid
modifi
selfassembl
nanoparticl
without
cage
structur
desir
nanoscal
properti
term
size
geometri
assembl
function
build
block
form
protein
nanoparticl
observ
natur
virus
seldom
mimick
gener
nanofabr
techniqu
intricaci
stem
select
protein
sequenc
promot
proteinprotein
interact
without
nonspecif
aggreg
protein
sequenc
deriv
natur
nonnatur
aminoacid
sequenc
lead
selfassembl
variou
pattern
natur
protein
scaffold
structur
alreadi
exist
natur
intrins
selfassembl
properti
includ
virus
ferritin
eukaryot
vault
contrast
synthet
protein
scaffold
design
de
novo
mimic
properti
natur
scaffold
carri
specif
function
advantag
natur
synthet
protein
scaffold
exploit
design
novel
function
architectur
specif
applic
protein
nanocag
drug
deliveri
discuss
review
molino
et
al
schoonen
et
al
review
focu
natur
synthet
protein
scaffold
engin
specif
function
group
impart
nonn
function
includ
aid
deliveri
activ
molecul
target
malign
cell
overcom
cellular
barrier
natur
scaffold
protein
scaffold
found
facilit
format
variou
inorgan
structur
natur
exampl
singlecel
alga
emiliania
huxleyi
form
fine
calcium
carbon
structur
call
coccolith
protein
control
format
structur
guid
assembl
crystallit
threedimension
structur
examin
molecular
level
show
complex
system
cell
use
protein
addit
phospholipid
physic
boundari
defin
separ
insid
cell
subcellular
compart
present
five
class
structur
distinct
size
morpholog
virus
ferritin
protein
vault
protein
nanocag
virus
virusbas
particl
year
studi
deduc
inform
viral
assembl
replic
infect
pathway
provid
clear
idea
stabil
function
virus
viral
transduct
observ
facilit
selfassembl
protein
structur
call
capsid
interact
host
cell
deliv
genom
target
cell
compart
outer
surfac
viral
capsid
open
sever
opportun
divers
chemic
function
sitespecif
modif
synthes
organicinorgan
materi
link
target
moieti
virus
innat
mechan
protect
genom
transfer
extracellular
environ
escap
immun
system
upon
reach
target
cell
interact
receptor
deliv
packag
nucleic
acid
desir
cell
compart
therefor
virus
use
function
carrier
target
deliveri
builtin
advantag
synthet
deliveri
vehicl
virus
domin
class
bionanoparticl
famili
size
rang
wide
nm
figur
addit
cell
target
abil
gene
deliveri
effici
proteinbas
multifacet
system
highli
order
spatial
configur
stabil
function
materi
alreadi
establish
intens
research
advanc
understand
viru
infect
replic
assembl
pathway
cowpea
mosaic
viru
cpmv
pdb
id
first
nanocag
among
virus
shown
conjug
varieti
function
molecul
nanocag
wellcharacter
plant
viru
produc
high
amount
composit
aminoacid
residu
viru
structur
well
understood
bioconjug
function
molecul
viru
stabl
wide
rang
ph
level
temperatur
organ
solvent
could
therefor
use
assembl
inorgan
nanoparticl
genet
engin
cpmv
possess
thiol
group
produc
coval
attach
gold
nanospher
nanospher
selfassembl
icosahedr
plasmon
nanoclust
follow
locat
thiol
group
cpmv
exhibit
increas
local
electromagnet
field
plasmon
nanoclust
uniqu
optic
properti
use
spectroscopi
cancer
treatment
multipl
orthogon
reactiv
site
viral
nanocag
establish
genet
engin
bioconjug
signal
moieti
biolog
recognit
motif
two
differ
aminoacid
residu
turnip
yellow
mosaic
viru
pdb
id
use
conjug
luminesc
terbium
complex
biotin
molecul
modifi
nanocag
use
scaffold
develop
sensor
timeresolv
fluoroimmunoassay
recent
advanc
select
chemic
modif
virus
viralbas
particl
broaden
scope
modul
bionanoparticl
beyond
genet
mutat
ferritin
ferritin
discov
novel
protein
structur
store
transport
iron
molecul
ferritin
isol
hors
spleen
contain
iron
nativ
structur
subsequ
found
exist
almost
ubiquit
biolog
system
bhaskar
lim
regul
storag
releas
iron
maintain
homeostasi
find
shed
light
idea
protein
use
encapsul
deliv
activ
molecul
vivo
first
xray
diffract
data
hors
spleen
ferritin
report
structur
crystal
structur
human
ferritin
first
report
cagelik
architectur
clearli
elucid
sinc
numer
ferritin
ferritinlik
protein
develop
exogen
applic
iron
storag
globular
multisubunit
cage
ferritin
store
iron
insolubl
nontox
state
keep
bioavail
within
cell
readili
convert
solubl
form
iron
central
caviti
maintain
small
crystallin
particl
organ
ferric
oxyhydroxid
form
ferritin
withstand
high
temperatur
wide
rang
ph
level
limit
period
without
signific
disrupt
cage
quaternari
structur
form
subunit
subunit
selfassembl
hollow
spheric
structur
outer
diamet
nm
intern
caviti
diamet
nm
figur
ferritin
iron
core
approxim
size
intern
diamet
critic
diamet
sever
molecular
characterist
includ
electrophoret
mobil
solubl
antigen
signific
properti
protein
shell
selfassembl
disassembl
properti
ferritin
nanocag
control
metal
ion
therebi
aid
uptak
releas
activ
molecul
protein
structur
similarli
structur
biochem
properti
ferritin
protein
use
tailor
wide
rang
applic
synthesi
nanoparticl
design
vaccin
biomedicin
protein
protein
deriv
core
domain
dihydrolipoamid
acetyltransferas
pyruv
dehydrogenas
multienzym
complex
protein
form
subunit
e
coli
subunit
geobacillu
stearothermophilu
selfassembl
hollow
structur
cubic
core
icosahedron
twelv
open
pdb
id
respect
pyruv
dehydrogenas
enzym
complex
compos
three
enzym
pyruv
decarboxylas
dihydrolipoamid
acetyltransferas
dihydrolipoamid
dehydrogenas
figur
shown
complex
produc
separ
compon
enzym
reassembl
vitro
form
nativ
structur
dissoci
presenc
enzym
evid
latter
form
structur
core
assembl
complex
g
stearothermophilu
thermophil
organ
henc
pyruv
dehydrogenas
complex
deriv
innat
stabil
allow
surviv
extrem
condit
unlik
nanocag
viral
capsid
modif
extern
surfac
function
ligand
hinder
assembl
core
domain
properti
ident
natur
state
domain
link
two
distinct
fold
protein
domain
surfac
similar
natur
protein
nanocag
protein
nanocag
subject
genet
chemic
modif
enabl
sever
function
drug
load
specif
target
protein
attach
ren
et
al
show
protein
modifi
intern
extern
surfac
load
drug
molecul
insid
display
function
epitop
outer
surfac
nanocag
simultan
thu
protein
cage
offer
promis
avenu
tailor
engin
exterior
subunitsubunit
interfac
interior
produc
desir
modif
vault
first
report
vault
ribonucleoparticl
mass
mda
found
eukaryot
cell
vault
barrellik
structur
measur
nm
extend
cap
extrem
hing
waist
region
nanostructur
consist
sever
highli
conserv
protein
includ
major
vault
protein
mvp
pdb
id
constitut
overal
mass
nanoparticl
vault
poli
adpribos
polymeras
vparp
telomeraseassoci
protein
untransl
rna
molecul
basic
vault
structur
consist
mvp
arrang
c
n
terminu
cap
waist
form
thin
protein
coat
cover
intern
caviti
n
terminu
tuck
toward
interior
vault
mvp
noncoval
associ
despit
strong
bind
mvp
vault
dynam
structur
open
close
transient
phenomenon
refer
breath
incorpor
small
molecul
protein
macromolecul
within
inner
core
peptid
extens
n
termini
shown
red
c
termini
shown
blue
waist
region
light
red
extrem
end
cap
respect
aa
b
fuse
exogen
protein
int
bind
site
ac
addit
peptid
n
terminu
ad
composit
assembl
multifunct
unit
could
form
ae
recombin
product
mvp
use
baculoviru
express
system
insect
cell
show
protein
structur
suffici
aid
direct
format
recombin
vault
particl
structur
analog
wildtyp
particl
natur
occur
vault
nanocag
thu
engin
wide
rang
novel
applic
natur
scaffold
bacteri
speci
found
host
selfassembl
nanoand
micros
structur
call
bacteri
microcompart
bmc
contain
protein
complex
form
copi
one
selfassembl
protein
speci
bmc
part
specif
metabol
pathway
cell
encapsul
unstabl
toxic
intermedi
metabolit
carboxysom
first
bacteri
organel
identifi
perform
function
describ
carboxysom
icosahedr
structur
crosssect
measur
nm
protein
coat
contain
distinct
protein
involv
autotroph
co
fixat
bacteria
via
rubisco
carbon
anhydras
enzym
similar
viral
capsid
format
carboxysom
icosahedr
structur
requir
combin
hexamer
pentamer
selfassembl
unit
bmc
protein
interestingli
selfassembl
properti
carboxysom
retain
vivo
even
delet
rubisco
enzym
flat
sheet
icosahedron
form
hexamer
unit
assembl
side
side
wherea
vertic
occupi
pentamer
unit
figur
common
bmc
subunit
consist
amino
acid
structur
proteinbas
organel
hyperthermophil
bacterium
thermotoga
maritima
refer
linocin
describ
smallest
bmc
measur
nm
diamet
later
protein
structur
renam
encapsulin
constant
effort
made
engin
natur
protein
sequenc
impart
new
addit
function
recent
studi
taken
effort
higher
level
creat
selfassembl
protein
structur
de
novo
design
assembl
small
peptid
occur
variou
noncoval
interact
van
der
waal
hydrophob
stake
electrostat
interact
hydrogen
bond
disulfid
bond
format
smallest
possibl
scale
small
protein
selfassembl
form
helic
bundl
consist
two
four
helic
design
focus
simpl
fold
pattern
particularli
coiledcoil
arrang
phenomenon
biolog
selfassembl
observ
amyloidogenesi
solubl
protein
transform
insolubl
aggreg
amyloid
fibril
chemic
specif
molecular
assembl
process
involv
domain
swap
symmetr
oligomer
could
consid
inspir
design
artifici
supramolecular
protein
structur
string
multipl
protein
domain
construct
modular
protein
allow
incorpor
multipl
function
singl
polypeptid
chain
modular
protein
use
vitro
condens
target
cell
deliveri
nucleic
acid
novel
approach
pave
way
design
varieti
proteindna
complex
deliv
nucleic
acid
therapeut
vitro
vivo
selfassembl
polypeptid
creat
leverag
natur
protein
oligomer
domain
form
higherord
structur
interfac
surfac
domain
tune
assembl
tetrahedr
octahedr
structur
yeat
group
leverag
symmetri
design
novel
protein
cage
two
subunit
fuse
geometr
predefin
manner
subsequ
selfassembl
highli
symmetr
structur
figur
design
principl
led
product
megadalton
protein
nanocag
icosahedr
symmetri
et
al
propos
differ
strategi
inspir
dna
origami
approach
polyhedr
structur
consist
individu
selfassembl
polypeptid
nanostructur
base
modular
orthogon
dimer
segment
format
dimer
segment
control
electrostat
hydrophob
interact
serv
platform
design
new
artifici
polypeptid
fold
figur
interlink
coiledcoil
segmentbas
design
lead
asymmetr
structur
bhaskar
lim
challeng
construct
assembl
organ
inorgan
subunit
enorm
size
exist
protein
structur
databas
could
aid
design
divers
class
selfassembl
structur
hybrid
protein
scaffold
expand
applic
diagnosticstherapeut
modul
immun
respons
protein
nanocag
conjug
moieti
ie
sugar
lipid
nucleotid
polym
result
hybrid
protein
scaffold
synthet
polym
conjug
virus
tobacco
mosaic
viru
adenoviru
cowpea
mosaic
viru
wide
report
hybrid
conjug
protein
scaffold
lucon
et
al
synthes
poli
methacryl
interior
viral
capsid
atomtransf
radic
polymer
produc
particl
increas
load
capac
magnet
reson
imag
mri
contrast
agent
gddtpa
protein
nanocag
could
enclos
within
polymer
shell
attach
coval
extern
surfac
protein
core
polymeriz
vinyl
group
graft
protein
polymer
crosslink
monom
favor
format
thin
polym
coat
around
protein
strategi
design
produc
protein
nanocag
nondegrad
degrad
polymer
shell
design
purpos
figur
similarli
introduc
certain
class
smart
polym
could
impart
stimulirespons
properti
protein
nanocag
smart
polym
design
sensit
extern
factor
heat
ph
magnet
field
enzymat
degrad
well
microenvironment
chang
instanc
pnipaam
poli
nisopropylacrylamid
wellknown
temperaturesensit
polym
undergo
revers
phase
chang
lose
water
solubl
lower
critic
solut
temperatur
matsumoto
et
al
produc
novel
biohybrid
nanoparticl
coval
linkag
pnipaam
recombin
cpmvp
cysteinerich
peptid
nterminu
mvp
vault
figur
result
polymer
particl
thermal
respons
expect
although
synthet
polymerprotein
nanocag
hybrid
wide
explor
report
sugar
polysaccharid
nucleotid
lipid
modif
limit
properti
carrier
deliveri
drug
contrast
agent
activ
molecul
consid
depend
target
specif
therapeut
index
achiev
certain
essenti
factor
includ
drug
efficaci
target
physiolog
environ
stabil
safeti
load
capac
drug
releas
kinet
carrier
carrier
measur
nm
favor
receptormedi
endocytosi
target
cell
membran
encapsul
advantag
nanocagebas
carrier
abil
decor
nanocarri
multipl
function
element
precis
uniformli
function
element
aid
carrier
abil
modul
immun
respons
penetr
effici
target
capabl
deliveri
activ
molecul
importantli
carrier
nontox
clinic
applic
three
main
properti
underli
design
drug
carrier
discuss
follow
subsect
ideal
drug
carrier
signific
biocompat
definit
biocompat
pertain
drug
deliveri
system
concis
review
kohan
langer
comprehens
review
naahidi
et
al
emphas
ideal
drug
carrier
devoid
intoler
toxic
thrombogen
carcinogen
immunogen
effect
carrier
sustain
host
long
enough
carri
intend
function
therefor
halflif
carrier
essenti
factor
ensur
effect
deliveri
vehicl
clear
biolog
system
perform
function
without
settl
organ
lead
longterm
side
effect
biocompat
carrier
nanoparticl
thu
rel
properti
depend
riskbenefit
ratio
regard
overal
role
without
caus
consider
damag
bodi
host
suitabl
type
carrier
use
might
vari
one
context
anoth
end
result
appropri
host
respons
one
major
concern
associ
protein
nanocarri
repeat
viruslik
structur
motif
immunogen
elev
engin
protein
cage
biomed
applic
bhaskar
lim
immunoglobulin
g
level
bcell
number
note
follow
singl
dose
heatshock
protein
cpmv
multipl
administr
could
thu
enhanc
immun
respons
neutral
carrier
nanocarri
clear
start
bind
protein
call
opsonin
mediat
phagocytosi
reticuloendotheli
system
host
common
modal
reduc
immunogen
respons
would
modifi
carrier
surfac
poli
ethyleneglycol
peg
polymethylmethacryl
poli
lacticcoglycol
acid
polyamidoamin
altern
method
includ
coat
polyket
glycan
shield
biodegrad
carrier
digest
cleav
bodi
often
chosen
nonbiodegrad
one
might
caus
toxic
side
effect
prefer
carrier
prepar
polysaccharid
eg
chitosan
protein
gelatin
biodegrad
synthet
polym
poli
lacticcoglycol
acid
polylact
acid
made
protein
protein
nanocag
natur
biodegrad
one
key
requir
drug
deliveri
system
effect
load
releas
drug
nanoparticl
carrier
strategi
use
choos
deliveri
system
reli
system
structur
function
natur
drug
carri
microenviron
drug
encount
deliveri
drugsact
molecul
facilit
chemic
immobil
noncoval
interact
environmentdepend
conform
chang
carrier
proteinbas
carrier
drug
could
chemic
conjug
posttransl
attach
drug
molecul
reactiv
side
chain
amino
acid
amin
carboxyl
sulfhydryl
hydroxyl
well
nonsid
chain
click
chemistri
coval
conjug
allow
adequ
control
releas
kinet
mode
drug
releas
chosen
base
conjug
chemistri
drug
carrier
cellular
microenviron
encount
interior
caviti
protein
nanocag
often
contain
natur
reactiv
site
attach
nucleic
acid
drug
metal
drug
molecul
may
also
load
nonspecif
interact
secondari
carrier
strong
affin
intern
surfac
carrier
nonspecif
interact
may
modul
drug
releas
kinet
physiolog
condit
diffus
nativ
pore
carrier
facilit
entri
central
caviti
gate
pore
certain
vlp
could
swell
open
low
salt
concentr
high
ph
osmot
shock
help
load
drug
condit
revers
drug
retain
prevent
outward
diffus
mechan
appli
deliv
drug
acid
cancer
microenviron
disassembl
reassembl
protein
cage
base
environment
condit
could
also
aid
drug
load
releas
releas
mechan
load
molecul
could
tune
introduc
repuls
forc
intersubunit
interfac
facilit
environ
eg
ph
trigger
dissoci
protein
subunit
nanocarri
target
nanoparticl
accumul
cancer
microenviron
enhanc
permeat
retent
epr
effect
due
leaki
vasculatur
tissu
nonspecif
accumul
enhanc
permeat
retent
effect
refer
passiv
target
may
effect
enhanc
affin
target
cell
carrier
decor
target
ligand
impart
activ
target
target
deliveri
drug
carrier
system
reduc
amount
drugcarri
complex
need
therapi
exampl
activ
target
ligand
peptid
rgd
present
adenovirus
natur
affin
upregul
integrin
receptor
endotheli
cell
tumor
vessel
attach
peptid
extern
surfac
carrier
aid
tumortarget
deliveri
certain
tumor
deliveri
platform
focu
target
surfac
receptor
use
natur
ligand
facilit
endocytosi
engin
protein
cage
biomed
applic
bhaskar
lim
folat
receptor
cancer
cell
transferrin
receptor
epiderm
growth
factor
receptor
although
mani
diseas
deliveri
system
target
research
focus
solid
tumor
cardiovascular
diseas
one
emerg
area
interest
modul
immun
respons
use
protein
carrier
applic
tumor
immunotherapi
treatment
autoimmun
diseas
ligand
use
biolog
target
includ
antibodi
engin
antibodi
eg
singlechain
variabl
fragment
nonnatur
peptid
ligand
nonnatur
peptid
ligand
often
identifi
use
phagedisplay
librari
provid
opportun
screen
multipl
ligand
differ
affin
toward
specif
cell
receptor
aptam
nucleotidebas
molecul
garner
interest
target
ligand
target
abil
carrier
depend
mainli
surfac
ligand
densiti
tune
protein
nanocag
suit
given
applic
engin
protein
scaffold
specif
biomed
applic
similar
nanoparticl
applic
protein
nanocag
biomedicin
involv
sever
challeng
lack
natur
capabl
carri
drug
lack
specif
low
cell
uptak
effici
absenc
endosom
escap
mechan
limit
circul
time
potenti
trigger
immunolog
respons
lack
tuneabl
releas
properti
furthermor
clinic
applic
nanocag
limit
structur
poor
stabil
cell
permeabl
overcom
challeng
engin
protein
nanocag
requir
impart
nonnatur
function
exampl
transloc
carrier
cell
endocytosi
alway
advantag
materi
digest
lysosom
rather
shuttl
target
cell
organel
henc
incorpor
endosom
escap
mechan
protein
nanocag
benefici
distinguish
nanocagebas
deliveri
system
inorgan
nanoparticl
spatial
control
function
group
ligand
attach
protein
structur
multifunct
properti
achiev
combin
desir
modif
load
target
chimer
assembl
lead
develop
smart
nanocarri
tremend
potenti
nanomedicin
select
coval
chemic
modif
protein
nanocag
made
leverag
nativ
amino
acid
lysin
glutam
acid
aspart
acid
cystein
tabl
provid
librari
natur
protein
cage
structur
chemic
genet
engin
impart
function
group
differ
cage
surfac
interior
exterior
intersubunit
interfac
structur
protein
nanocag
offer
three
distinct
surfac
engin
interior
exterior
intersubunit
interfac
figur
interfac
exploit
induc
chemic
genet
modif
variou
purpos
modif
also
made
reaction
condit
provid
opportun
control
size
posit
orient
load
extern
activ
molecul
interior
modif
protein
nanocag
interior
caviti
protein
nanocag
provid
ideal
contain
molecular
cargo
tailor
cage
interior
increas
encapsul
effici
bind
affin
modul
releas
profil
genet
chemic
alter
made
precis
locat
manipul
nucleat
attach
molecul
molecular
cargo
small
molecul
peptid
protein
drug
rnadna
drug
imag
agent
polym
encapsul
releas
interior
protein
nanocag
antibodi
potenti
cargo
larger
protein
nanocag
vault
modif
nanocag
interior
introduc
cystein
residu
wide
use
approach
modif
facilit
coval
attach
dye
molecul
drug
activ
molecul
disulfid
bond
modif
includ
introduct
phenylalanin
attach
lipid
substanc
polym
insid
cage
architectur
attach
polym
chain
interior
surfac
offer
spatial
control
reactiv
site
shown
stabil
cage
abedin
et
al
creat
polym
network
insid
protein
cage
introduc
cystein
reactiv
residu
genet
manipul
polym
network
creat
sequenti
conjug
multifunct
monomer
unit
click
chemistri
allow
free
amin
incorpor
polym
intern
function
figur
polym
network
coval
crosslink
subunit
protein
cage
increas
thermal
stabil
least
exterior
modif
protein
nanocag
exterior
surfac
protein
nanocag
engin
impart
increas
circulatori
halflif
local
accumul
cellular
penetr
trigger
specif
cellular
respons
uniqu
geometri
protein
nanocag
allow
multipl
ligand
function
molecul
display
surfac
modifi
molecul
includ
small
molecul
eg
folat
peptid
eg
rgd
transactiv
transcript
peptid
cell
penetr
peptid
immunoglobulin
g
bind
peptid
z
domain
antibodi
eg
antiepiderm
growth
factor
receptor
nucleotid
eg
dna
rna
aptam
polym
eg
peg
pga
poli
lacticcoglycol
acid
polymethacryl
polyamidoamin
exterior
surfac
cpmv
cowpea
chlorot
mottl
viru
ccmv
bacteriophag
qb
modifi
antibodi
peptid
transferrin
cell
transduct
domain
cellpenetr
peptid
adenovirusbas
peptid
rgd
natur
affin
integrin
receptor
upregul
tumor
vessel
modif
protein
carrier
peptid
proven
aid
tumor
target
short
singlestrand
oligonucleotid
call
aptam
secondari
structur
capabl
recogn
specif
molecul
incorpor
onto
nanoparticl
enhanc
specif
aptam
bind
extracellular
membran
intracellular
protein
thu
facilit
aptamernanoparticl
conjug
therapi
function
impart
nanocag
attach
function
ligand
extend
halflif
eg
peg
enhanc
penetr
cell
eg
cell
penetr
peptid
folatepeg
display
adenovir
nanoparticl
deliv
folat
receptoroverexpress
cell
nanocarri
proven
decreas
level
macrophag
show
engin
viral
scaffold
counteract
innat
immun
respons
peg
act
stealth
layer
shield
immunogen
epitop
surfac
nanocag
structur
layer
prevent
protein
opsonin
adsorb
onto
surfac
therebi
shunt
recognit
nanocag
phagocyt
cell
reticuloendotheli
system
peg
modif
also
benefit
tuneabl
solubl
structur
integr
protein
nanocag
spatial
control
multifunct
group
protein
nanocag
equip
hierarch
selfassembl
display
distinct
function
ligand
display
multipl
type
ligand
precis
arrang
nanoparticl
challeng
distinct
advantag
protein
nanocag
nanoparticl
posit
amino
acid
spatial
defin
allow
precis
spatial
control
display
ligand
n
c
termini
nanocag
subunit
engin
protein
cage
biomed
applic
bhaskar
lim
face
extern
surfac
natur
choic
display
function
ligand
fusion
short
peptid
termini
achiev
genet
engin
modif
recombin
vault
fuse
cysteinerich
peptid
n
terminu
mvp
cpmvp
lead
increas
particl
stabil
engin
vault
mvp
ctermin
region
tag
epitop
immunoglobulin
gbind
peptid
z
domain
epiderm
growth
factor
display
cap
vault
shown
facilit
cellspecif
target
anoth
approach
domingo
et
al
denatur
mix
reassembl
protein
subunit
carri
differ
chimer
peptid
display
multipl
type
ligand
ie
green
fluoresc
protein
two
type
malaria
epitop
surfac
singl
protein
nanocag
display
two
type
hivderiv
antigen
epitop
provok
specif
antibodi
tcell
respons
despit
natur
spatial
control
protein
nanocag
achiev
desir
symmetri
still
great
challeng
product
protein
nanocag
dual
architectur
achiev
toposelect
modifi
exterior
surfac
dnabind
protein
starv
cell
cage
maskingunmask
method
base
solid
support
distribut
two
function
domain
fluorophor
affin
tag
manipul
use
differ
materi
solid
support
figur
toposelect
modif
provid
sophist
design
multifunct
nanoplatform
combin
genet
fusion
toposelect
attach
streptavidin
univers
coupl
protein
biotinyl
molecul
could
attach
suci
et
al
achiev
asymmetr
placement
streptavidin
asymmetr
placement
provid
spatial
control
display
provid
tool
explor
effect
polar
orient
conjug
function
molecul
interact
specif
cell
surfac
receptor
intersubunit
modif
selfassembl
nanostructur
cell
depend
specif
proteinprotein
interact
understand
interact
essenti
design
novel
nanostructur
variou
applic
exampl
control
assembl
disassembl
process
respond
ph
variat
implic
releas
molecular
cargo
protein
nanocag
trigger
includ
salt
concentr
nucleic
acid
content
well
metal
ion
display
ligand
also
modul
modifi
subunit
interact
interfac
subunit
virus
ccmv
studi
determin
mechan
supramolecular
assembl
protein
nanocag
indepth
studi
interact
protein
subunit
interfac
pave
way
optim
condit
induct
selfassembl
genet
modif
specif
locat
subunit
especi
n
c
termini
yield
vlp
differ
size
total
number
subunit
ccmv
viral
cage
also
test
term
low
symmetr
assembl
two
differ
strategi
develop
break
symmetri
ligand
present
viru
ccmv
nanoparticl
label
differ
either
biotin
digoxigenin
disassembl
individu
subunit
figur
differenti
label
subunit
purifi
mix
reassembl
optim
stoichiometri
form
dualfunct
nanocag
control
display
ligand
maximum
benefit
strategi
reap
function
nanocag
structur
assembl
base
librari
differenti
engin
subunit
ligand
epitop
proteinprotein
interact
often
involv
larg
area
buri
surfac
interrupt
small
molecul
target
engin
protein
cage
biomed
applic
bhaskar
lim
hot
spot
energi
bind
concentr
zhang
et
al
identifi
hot
spot
dnabind
protein
starv
cell
alanin
shave
method
method
work
conceptu
shave
individu
side
chain
methyl
residu
stabil
result
mutant
deduc
compar
wild
type
work
could
aid
basic
understand
assembl
miniferritin
control
ferritin
oligomer
state
appli
templat
nanomateri
synthesi
drug
deliveri
modifi
interact
subunitsubunit
interfac
assembl
profil
protein
nanocag
modifi
stabl
ph
disintegr
acid
ph
word
ph
transit
point
chang
occur
control
use
strategi
releas
encapsul
drugact
molecul
achiev
modul
interact
subunit
respond
ph
chang
target
cell
microenviron
exampl
tumor
microenviron
slightli
acid
healthi
tissu
ph
chang
also
experienc
molecul
enter
cell
endocytosi
molecul
experi
ph
level
near
cell
ph
level
upon
enter
lysosom
later
pathway
thu
phbase
assembl
disassembl
respond
could
use
trigger
releas
molecul
encapsul
within
protein
nanocag
engin
product
protein
nanocag
protein
nanocag
plastic
power
materi
low
toxic
function
divers
flexibl
suitabl
engin
specif
purpos
construct
protein
nanocag
build
block
could
achiev
select
protein
domain
facilit
proteinprotein
interact
without
nonspecif
aggreg
environment
paramet
temperatur
ph
use
control
peptid
selfassembl
addit
function
ligand
incorpor
natur
exist
protein
nanocag
genet
engin
chemic
modif
techniqu
genet
engin
protein
nanocag
achiev
recombin
dna
technolog
produc
small
larg
scale
use
microbi
nonmicrobi
system
cell
factori
bacteri
cell
particular
popular
host
produc
varieti
nanomateri
includ
medic
applic
chemic
modif
use
prevent
interbatch
variabl
protein
product
observ
recombin
dna
technolog
franci
group
develop
new
method
chemic
modifi
protein
may
applic
protein
nanocag
applic
protein
nanocag
druggen
carrier
leverag
facil
genet
chemic
modif
promot
molecular
attach
encapsul
protein
nanocag
engin
carri
drug
gene
imag
contrast
agent
activ
molecul
date
small
molecul
doxorubicin
bleomycin
cisplatin
carboplatin
nucleic
acid
dnarna
peptid
protein
cre
recombinas
deliv
vitro
wherea
paclitaxel
doxorubicin
small
interf
rna
microrna
cpg
oligo
appli
vivo
therapeut
use
protein
nanocag
coval
attach
small
molecul
interior
protein
nanocag
prevent
leakag
protect
drug
prevent
degrad
prevent
nonspecif
interact
instanc
low
endosom
ph
cell
could
use
trigger
releas
encapsul
drug
heatshock
protein
cage
interior
protein
modifi
genet
insert
cystein
residu
interior
surfac
select
attach
antitumor
drug
phsensit
linker
attach
hydrazon
deriv
doxorubicin
inner
surfac
cysteinemodifi
heatshock
protein
protein
nanocag
allow
select
releas
drug
acid
condit
hydrolysi
hydrazon
linkag
ferritin
use
encapsul
platinumbas
anticanc
drug
cisplatin
carboplatin
drug
encapsul
within
protein
nanocag
report
retain
efficaci
exert
cytotox
effect
cancer
cell
howev
efficaci
comparison
encapsul
drug
free
drug
effect
healthi
cell
still
investig
vlp
brome
mosaic
viru
ccmv
papillomaviru
polyomaviru
use
packag
deliv
exogen
dna
pan
et
al
use
bacteriophag
vlp
deliv
human
premirna
nanocag
simultan
decor
cellpenetr
peptid
transactiv
transcript
enhanc
cellular
penetr
design
deliveri
vehicl
promot
subcellular
local
nucleic
acid
suppress
target
gene
effect
small
interf
rna
encapsul
hbv
capsid
nanocarri
shown
system
deliv
small
interf
rna
cancer
site
mice
effect
silenc
target
gene
protein
nanocag
also
explor
carrier
proteinbas
therapeut
deliveri
protein
therapeut
requir
protein
nanocag
larger
caviti
model
therapeut
molecul
prodrug
enzym
packag
vlp
fuse
gag
protein
viral
vector
natur
taken
cell
interact
envelop
protein
outer
surfac
cell
receptor
vsvg
envelop
local
target
ligand
increas
effici
deliveri
cargo
particular
cell
vault
volum
nm
good
nonvir
protein
nanocag
candid
packag
proteinbas
therapeut
load
facilit
fuse
protein
interest
int
serv
shuttl
protein
packag
molecul
insid
vault
modif
vault
interior
exterior
accommod
therapeut
ligand
review
section
basic
requir
vitro
vivo
imag
achiev
high
local
concentr
imag
agent
suppress
quench
fluoresc
probe
variou
contrast
agent
enhanc
mri
positron
electron
tomographi
near
infrar
fluoresc
imag
encapsul
protein
nanocag
singl
coencapsul
contrast
agent
allow
develop
protein
nanocag
multimod
imag
abil
protein
nanocag
ferritin
domin
bioimag
applic
inher
abil
ferritin
store
iron
ferric
oxyhydroxid
particl
make
attract
mri
contrast
agent
ferric
oxyhydroxid
nanoparticl
superparamagnet
therefor
endogen
ferritin
load
particl
act
natur
mri
contrast
agent
clinic
signific
magnet
field
strength
ie
ferritin
less
relax
per
iron
commerci
produc
iron
oxid
nanoparticl
load
superparamagnet
iron
oxid
nanoparticl
ferritin
nanocag
show
higher
r
relax
endogen
ferritin
protein
nanocag
engin
chemoselect
manner
increas
load
capac
fluorophor
eg
alexa
fluor
fluorescein
dye
cpmv
precis
defin
posit
exterior
interior
cage
imag
agent
attach
rigid
order
protein
structur
distinct
posit
spatial
confin
dye
molecul
prevent
react
aggreg
therefor
reduc
quench
possibl
inher
abil
nearinfrar
fluoresc
dye
penetr
tissu
reduc
background
nois
make
attract
vivo
imag
attach
dye
protein
nanocag
increas
local
concentr
result
reduc
dose
notabl
exampl
luminesc
semiconductor
nanocryst
quantum
dot
display
engin
cpmv
nanocag
bacteriophag
nanocag
test
abil
carri
positron
electron
tomographi
imag
agent
f
fluorobenzaldehyd
radiolabel
attach
interior
cage
bioconjug
positron
electron
tomographi
imag
analysi
rat
show
conjug
protein
nanocag
increas
blood
circul
time
imag
agent
without
affect
biodistribut
protein
nanocag
also
use
contrast
agent
ultrasound
imag
gasfil
protein
base
nanostructur
deriv
cyanobacterium
anabaena
flosaqua
genet
engin
enhanc
harmon
properti
optim
vitro
vivo
ultrasound
imag
shown
protein
nanocag
also
engin
multimod
target
ultrasound
imag
imag
modal
uniqu
advantag
tissu
penetr
depth
spatial
tempor
resolut
cell
specif
combin
multipl
molecular
probe
differ
imag
modal
allow
accur
diagnosi
diseas
condit
date
nearinfrar
fluorescencepositron
electron
tomographi
multimod
imag
use
protein
nanocag
report
ferritin
use
carrier
deliv
two
imag
probe
cu
target
ligand
imag
tumor
applic
protein
nanocag
vaccineimmun
modul
protein
nanocag
shown
promis
potenti
display
platform
pathogen
epitop
elicit
product
neutral
antibodi
hbv
hpv
influenza
hiv
hepat
c
viru
rsv
chlamydia
infect
cancer
cervic
cancer
tumor
diseas
target
vaccin
develop
use
protein
nanocag
platform
current
vaccin
mostli
base
whole
virus
live
attenu
inactiv
edward
jenner
present
first
virusbas
vaccin
small
pox
sinc
vaccin
enter
market
includ
vaccin
hepat
rubella
measl
mump
influenza
despit
initi
success
live
attenu
viral
vaccin
rel
less
stabl
difficult
administ
also
risk
attenu
virus
revert
pathogen
form
detriment
host
neutral
viru
vaccin
carri
risk
revers
weaker
expens
exhibit
reduc
vaccin
coverag
given
popul
overcom
problem
subunit
vaccin
consid
prime
immun
respons
administr
preload
viral
protein
often
taken
viral
capsid
engin
protein
cage
biomed
applic
bhaskar
lim
portion
viral
replic
vaccin
safer
less
immunogen
produc
purifi
without
viral
counterpart
howev
innat
abil
viral
capsid
subunit
assembl
vlp
could
use
mimic
whole
viru
improv
vaccin
efficaci
vlp
could
also
use
platform
display
foreign
ligand
viral
nonvir
origin
envelop
nonenvelop
vlpbase
vaccin
develop
two
success
nonenvelop
vlpbase
vaccin
name
hbv
hpv
vaccin
licens
commerci
clinic
applic
virus
influenza
hepat
c
viru
hiv
give
rise
envelop
vlp
lack
abil
replic
immunogen
compos
assembl
particl
consist
surfac
subunit
plasma
membran
current
research
focus
conserv
epitop
envelop
protein
develop
success
hiv
vaccin
requir
engin
differ
vlp
develop
vlpbase
vaccin
hepat
c
viru
filovirus
ebola
viru
marburg
viru
sever
acut
respiratori
syndrom
coronaviru
chikungunya
viru
rapidli
progress
plant
virus
also
use
platform
display
antigen
epitop
cpmv
extens
studi
plant
viru
vaccin
applic
plant
virus
includ
cmv
papmv
bacteriophag
insect
viru
platform
also
explor
heterolog
epitop
display
varieti
cancer
vaccin
could
develop
use
tolllik
receptor
agonist
cpg
peptideload
protein
nanocag
vaccin
respiratori
infect
influenza
respiratori
syncyti
viru
explor
specif
hemagglutinin
fuse
genet
ferritin
subunit
eight
trimer
viral
spike
present
outer
surfac
selfassembl
nanocag
figur
respiratori
syncyti
viral
epitop
display
vlp
baculoviru
newcastl
diseas
viru
chlamydia
trachomati
immunogen
epitop
vault
nanocag
vagin
inject
mice
stimul
specif
tcell
respons
pathogen
engin
protein
nanocagebas
vaccin
shown
induc
protect
immun
protein
nanocag
versatil
platform
biomed
applic
main
advantag
protein
nanocag
spatial
control
function
group
display
welldefin
locat
genet
chemic
modif
date
nanoplatform
provid
abil
simultan
tune
size
shape
biocompat
protein
nanocag
shown
amen
engin
cater
specif
function
despit
multitud
function
detail
mechan
uptak
protein
nanocag
intracellular
fate
fulli
understood
although
cell
intern
carrier
molecul
effici
deliveri
intend
intracellular
compart
remain
challeng
decor
protein
nanocag
ligand
cellpenetr
peptid
appear
improv
deliveri
drug
cargo
cell
via
nonspecif
cellular
uptak
improv
select
enhanc
local
accumul
target
cell
target
agent
display
extern
surfac
protein
scaffold
advantag
spatial
control
ligand
attach
protein
nanocag
howev
limit
respect
display
differ
type
ligand
nanocag
engin
peptid
protein
could
crucial
role
creat
multifunct
materi
combin
two
distinct
ligand
singl
protein
nanocag
select
display
peptid
protein
nucleotid
spatial
control
may
open
new
avenu
design
develop
novel
selfassembl
function
hierarch
supramolecular
structur
wherea
similar
approach
pursu
gener
field
nanotechnolog
still
remain
challeng
protein
nanocag
may
present
new
opportun
although
major
effort
focus
use
protein
nanocag
deliv
anticanc
drug
exploit
protein
nanocag
modul
immun
respons
emerg
area
research
potenti
attract
applic
protein
nanocag
good
candid
deliv
immun
modul
agent
applic
cancer
immunotherapi
autoimmun
diseas
treatment
natur
virus
innat
abil
condens
deliv
nucleic
acid
cell
receptor
interact
studi
structur
function
protein
subunit
virus
respons
packag
releas
nucleic
acid
novel
gene
deliveri
system
construct
de
novo
limit
explor
includ
use
protein
nanocag
treatment
skin
condit
pigment
disord
ocular
deliveri
therapeut
develop
vast
applic
protein
nanocag
requir
deeper
understand
fundament
concept
bhaskar
lim
remain
understudi
exampl
selfassembl
mechan
mani
protein
nanocag
remain
elus
detail
mechanist
understand
import
better
design
drug
load
releas
properti
mechan
intern
intracellular
process
nanoparticl
yet
determin
although
cellspecif
deliveri
protein
nanocag
possibl
target
effici
carrier
present
major
challeng
addit
penetr
physiolog
barrier
epiderm
skin
layer
corneal
layer
yet
address
advent
synthet
biomateri
artifici
peptid
modular
protein
polym
widen
scope
addit
properti
revers
aggreg
complement
natur
scaffold
design
hybrid
nanoscaffold
de
novo
via
natur
bottomup
approach
use
smart
synthet
materi
could
provid
critic
advantag
biocompat
sitespecif
modif
control
selfassembl
respect
environment
stimulu
stabil
drugnucl
acid
load
novel
bioinspir
materi
form
selfassembl
distinctli
engin
protein
subunit
variou
function
immens
valu
nanomedicin
associ
medic
field
